DCM
TDOC icon

Deuterium Capital Management’s Teladoc Health TDOC Stock Holding History

Deuterium Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,000
Closed -$159K – 39
2025
Q1 		$159K Buy
+20,000
New +$202K 0.35% 25
2022
Q4 		– Sell
-6,000
Closed -$352K – 73
2022
Q3 		$352K Buy
+6,000
New +$210K 1.47% 14
2022
Q2 		– Sell
-3,000
Closed -$216K – 85
2022
Q1 		$216K Hold
3,000
– – 0.28% 64
2021
Q4 		$275K Buy
+3,000
New +$359K 0.41% 48

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

Deuterium Capital Management's TDOC Position: Q2 2025 in Review

Deuterium Capital Management sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 20,000 shares — an estimated $159K sold.

Deuterium Capital Management first reported a position in TDOC in Q4 2021 and held it in 4 quarters. The position peaked at $352K in Q3 2022. 358 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Deuterium Capital Management reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Deuterium Capital Management sold 20,000 Teladoc Health shares in Q2 2025, an estimated $159K.
  • Deuterium Capital Management first reported a position in Teladoc Health in Q4 2021 and held it in 4 quarters.
  • Deuterium Capital Management's Teladoc Health position peaked at $352K in Q3 2022.
  • 358 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Deuterium Capital Management's 13F filing for Q2 2025, filed 4 Aug 2025.